v


Central China's First Single-Port Robotic Resection of Mediastinal Tumor Completed

 

In a regional milestone for minimally invasive thoracic surgery, Dr. Weijiang Huang and his team at Xiaogan Central Hospital successfully performed Central China’s first single-port robotic resection of a large anterior mediastinal tumor. The 44-year-old patient presented with chest tightness and was diagnosed with an 8 cm mass closely adherent to the heart—making traditional open surgery highly invasive and risky.

 

 

Leveraging the SHURUI® single-port surgical system, the team accessed the tumor via a right thoracic approach, using flexible snake-like instruments and high-definition 3D vision for precise dissection and reduced surgical trauma. The procedure was completed in just one hour with a sub-3cm incision. The patient began recovery rapidly, resuming liquid intake the same night and walking the next day.

 

This breakthrough marks a significant advancement for thoracic surgery in Central China, bringing world-class precision and ultra-minimally invasive care closer to home.

 

Important Notes

The SHURUI Single-port Endoscopic Surgical System (SR-ENS-600), developed and produced by Beijing Surgerii Robotics Company Limited, has obtained the CE marking for urologic laparoscopic surgical procedures, gynecologic laparoscopic surgical procedures, general laparoscopic surgical procedures, and thoracoscopic surgical procedures. It is intended for use by trained surgeons in an operating room environment in accordance with the representative, specific procedures set forth in the User Manual.

Safety and Performance Information

Beijing Surgerii Robotics Co., Ltd. owns Surgerii®, SHURUI®, and other trademarks and may not be used without permission.